HopeStage
Back to all studies
CompletedNCT00328978

Quetiapine 800 mg or higher for schizophrenia not responding to treatment

About this titleRead the official source — NCT00328978
Medication studyAges 18–65Canada
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Calgary and 16 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2003
Recruitment status
Completed
Enrollment listed in the registry
330
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT00328978
Official title
Show the full official title

A Canadian, Multicenter, Double-Blind, Randomized, Parallel-Group Study of the Safety, Tolerability, and Efficacy of Treatment With Higher Doses of Quetiapine Fumarate (Seroquel®) Greater Than 800 mg/Day in Schizophrenic or Schizoaffective Subjects.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Calgary · Edmonton · West Claresholm

14 more locations
  • Victoria
  • White Rock
  • Winnipeg
  • Sydney
  • Kingston
  • London
  • Markham
  • Mississauga
  • Ottawa
  • Windsor
  • Montreal
  • Québec
  • Verdun
  • Saskatoon

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is AstraZeneca.

Did this study involve medication?

Yes. The study involved medication, including Quetiapine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies